	Injection Site Pain Levels with Biologic Medications for Atopic Dermatitis and Psoriasis: A Real-Life Study. J Am Acad Dermatol Karpoff K, Lau WC, Lebwohl M. PMID: 42562102 [PubMed - as supplied by publisher]
	Melittin attenuates imiquimod-induced psoriatic dermatitis in mice: a role for autophagy activation via PI3K/Akt/mTOR pathway suppression. Saudi Pharm J Hafez SA, Ahmed AA, Elkhoely A, Ahmed AAE. PMID: 42560464 [PubMed]
	Drug-associated psoriasis: a pharmacovigilance study based on the FAERS database. Front Pharmacol Yi S, Liu A, Huoshen W, Xia D, Ma X. PMID: 42558881 [PubMed]
	Short-term efficacy of biologics targeting the IL-17/IL-23 axis in scalp, nail, and palmoplantar psoriasis: a network meta-analysis of randomized controlled trials. Front Immunol Zhang S, Lam T, Du Y, Chen X, Zhang H, Li L, Zhang G. PMID: 42558790 [PubMed - indexed for MEDLINE]
	Safety and Efficacy of Deucravacitinib in Japanese Patients With Moderate to Severe Plaque Psoriasis: 5-Year Analysis of the Phase 3 POETYK PSO-1, PSO-4, and Long-Term Extension Trials. J Dermatol Okubo Y, Morita A, Tada Y, Imafuku S, Armstrong AW, Blauvelt A, Vaile J, Popmihajlov Z, Li J, Sawant R, Habiro K, Tsuritani K, Ohtsuki M. PMID: 42557591 [PubMed - as supplied by publisher]
	Efficacy and safety of vunakizumab in patients with moderate-to-severe plaque psoriasis with a high drug interruption rate during the COVID-19 pandemic: a post hoc analysis from a single center of a phase III trial. Naunyn Schmiedebergs Arch Pharmacol Wang S, Zhang Z, Han L, Yan K, Xu J. PMID: 42557368 [PubMed - as supplied by publisher]
	Psoriatic patients with cancer: a multicentric real-life study comparing Risankizumab and Apremilast. Dermatology Raimondo A, Balato A, Guarneri C, Ligrone L, Manzo R, Megna M, Musumeci ML, Palazzo G, Puca RV, Romano F, Lembo S. PMID: 42555537 [PubMed - as supplied by publisher]
	Efficacy of Heartfulness Meditation as Adjunctive Therapy for Moderate to Severe Psoriasis: A Randomised Controlled Trial. Indian J Dermatol Nagendran P, Subramanian SK, Satyanarayanan, Sripad VD, Rajendran R, Gopinath H, Sravanthi KL, Thiruveedhula H. PMID: 42555361 [PubMed]
	INDIVIDUAL ARTICLE: Generalized Pustular Psoriasis: A Contemporary Review of Diagnosis, Pathophysiology, and IL-36 Pathway-Directed Management. J Drugs Dermatol Issa NT, Lebwohl M, Chovatiya R, Kircik L. PMID: 42555081 [PubMed - indexed for MEDLINE]
	Impact of Intermittent Fasting, Keto Diet vs Continuous Caloric Restriction on Psoriasis Severity: A Systematic Review and Meta-Analysis Protocol. J Drugs Dermatol Alqefari AN, Almutairi HM, Almohaimeed MY, Aldossari AA, Alqefari G, Alsaleam A, Alzolibani AA, Alhameedy M. PMID: 42555076 [PubMed - indexed for MEDLINE]
	Improved Sleep Quality in Psoriasis Patients Under Biologicals: A Prospective Observational Study. J Drugs Dermatol De Luca DA, Papara C, Pommerien L, Hawro T, Thaçi D. PMID: 42555075 [PubMed - indexed for MEDLINE]
	Speed of Response in Biologic Treatments for Moderate-to-Severe Plaque Psoriasis: Bayesian Network Meta-Analysis. J Drugs Dermatol Shami MZ, Amara S, Shimon SV, Kest I, Islam RK, Moffatt L, Lebwohl M. PMID: 42555067 [PubMed - indexed for MEDLINE]
	Assessing Accuracy of ChatGPT in Identifying Contact Allergens in Commonly Prescribed Topical Therapies for Psoriasis. J Drugs Dermatol Fong S, Flamm A, Zampella JG. PMID: 42555065 [PubMed - in process]
	Comprehensive Analysis of Comorbidities Associated With Psoriasis Diagnosis in the MEPS National Cohort. J Drugs Dermatol Adler R, Gandhi I, Edwards T, Svigos K, Jakus J. PMID: 42555064 [PubMed - in process]
	Risankizumab Associated With Lower Incident Depression and Sleep Disorders in Psoriasis: A TriNetX Study. J Drugs Dermatol Garfinkel V, Feron H, Nezafati K. PMID: 42555063 [PubMed - in process]
	Association Between Psoriasis and Overactive Bladder Among US Adults: A Study Based on 2005-2006 and 2009-2014 National Health and Nutrition Examination Survey. Neurourol Urodyn Zhuo X, Wang J, Wang X, Wen P. PMID: 42554142 [PubMed - as supplied by publisher]
	Predicting comorbidities in psoriasis using TCM constitution and multimodal data: a prospective cohort study protocol. Front Med (Lausanne) Hu J, Long D, Chen J, Luo M, Zhou R, Zhang X, Lei Z, Deng W, Kuang Y, Wang H. PMID: 42553580 [PubMed]
	Evaluating Zasocitinib as an oral therapy for moderate to severe plaque Psoriasis. Expert Opin Pharmacother McGuirt V, Razler D, Moore SG, Feldman S. PMID: 42552595 [PubMed - as supplied by publisher]
	Mechanistic insight into Solanum lyratum extract for ameliorating imiquimod-induced psoriasis in mice via suppression of mast cells and Th17 cell response. Fitoterapia Jin S, Chen J, He Y, Guo Y, Zhang J, Zhang Z, Ye F, Chen G. PMID: 42551598 [PubMed - as supplied by publisher]
	Patients with Psoriatic Arthritis Have Increased Dental Comorbidities: A Nationwide Population-based Cohort Study in Korea. Acta Derm Venereol Kong S, Kim KE, Kwak EJ, Kim HN, Kim A, Jeon J, Park CM, Baek YS. PMID: 42549605 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 28353

Page 1 of 1418



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy